Too Many Dead
An inquiry into Australia's excess mortality
It may at first seem an extraordinary thing to say, but the fact is that Australia is currently experiencing a prolonged elevated rate of death across all age groups. An examination of the official figures shows rates in the vicinity of 12-17% above baseline averages, rates never seen since wartime. They leapt up in early 2021 and continue at unusual levels to this day.
In response to the globally declared COVID-19 pandemic, Australian medical and political authorities enforced unscientific and profoundly unethical public health measures such as extended lockdowns, border closures, school closures, forced masking and mandated novel vaccines still clearly in the experimental phase of development.
There is no credible evidence that the non-pharmaceutical or pharmaceutical public health interventions enforced reduced mortality and kept people “safe”.
The unprecedented excess deaths being seen in Australia are also being seen globally, with many countries witnessing disturbing trends in death from all causes, the majority of which are not attributable to COVID-19.
The scale of death suggests we are in the midst of an actual disaster. The fact that it appears silent alters nothing. Too many extra Australians are dying and yet almost none of our public health officials, politicians or medical colleges and associations seem interested in finding out why. We seem to be confronted by administrative wilful blindness. Failure of the authorities to seek answers in fact shows a reckless disregard for the lives of Australians. It is past time for us to demand an answer to what is causing these deaths and how to stop them. If the government really cares about keeping people “safe” why is there such a refusal to inquire?
Senator Ralph Babet put forward two motions in the Senate seeking acknowledgement and an investigation into Australia’s concerning excess death data. On March 23rd, 2023 he proposed a select committee of inquiry.
Senator Babet pursuant to notice of motion not objected to as a formal motion, moved a general business notice of motion no. 194 -
- That a select committee, to be known as the Select Committee on Australia’s Excess Mortality, be established to inquire into and report on (this issue)….
But the motion was defeated 35 to 4. Then again, regarding the Australian Bureau of Statistics Mortality date, on March 24th, 2023, a motion was moved by Senator Babet asking that the Senate acknowledge:
- There has been a concerning number of excess deaths in Australia in 2021 and 2022, as evidenced by recent all-cause provisional mortality data from the Australian Bureau of Statistics, and
- There is a need for further inquiry and scrutiny as to the reasons for these excess deaths, including why dementia and diabetes have seen significant increases in recent years.
The motion was defeated 30 to 29.
Since it appears those who have been entrusted to serve and protect the people refuse to fulfil their duty to seek answers, the Australian Medical Professionals’ Society will do so. AMPS, as an association of medical professionals dedicated to ethical evidence-based healthcare, is undertaking an inquiry that no one else will address. It is our duty as health professionals to make our patient’s health and safety our first priority. AMPS will be holding an inquiry into Australia’s excess mortality on Wednesday, October 18th in Parliament House, Canberra. We have called for submissions from national and international experts as well as from the TGA, ATAGI and the Department of Health.
The number of dying Australians constitutes an unfolding catastrophe and we owe it to all those dead Australians and their grieving families and friends to investigate what is killing people at such an alarming rate. Failing to seek answers is negligent and far beyond disrespectful.
The results of this inquiry will be made available to all Australians. The published report will be provided to all stakeholders, medical regulatory and political authorities, and to medical colleges and associations.
Your donation to assist in covering the cost of publishing this book is greatly appreciated.
Any excess donations will go towards our medico-legal fighting fund.
EXCESSIVE DEATHS CONFERENCE
You can find more information here
Presenters & Inquiry Contributors
Your donation to assist in covering the cost of publishing this book is greatly appreciated.
Any excess donations will go towards our medico-legal fighting fund.
Dr Clare Craig
Dr Clare Craig is a qualified pathologist, who worked in the NHS and reached consultant level in 2009.
She specialised in cancer diagnostics and diagnostic testing within mass screening programmes.
She was the day-to-day pathology lead for the cancer arm of the 100,000 Genomes Project.
She was the clinical lead for the data team and led research and development projects at Genomics England writing
national guidance and helping build bespoke software.
Dr Craig has been a tireless voice, on and offline, over the past several years in advocating for evidence-based policy around Covid issues,
and the importance of upholding basic medical ethical principles including informed consent and bodily autonomy.
She is Co-chair of the Health Advisory and Recovery Team, a voluntary body of professionals educating the public on COVID issues.
Her first book, Expired - Covid The Untold Story, is out now on Amazon.
Professor Norman Fenton
Norman is Professor Emeritus of Risk at Queen Mary University of London (retired as Full Professor Dec 2022) and a Director of Agena, a company that specialises in artificial intelligence and Bayesian probabilistic reasoning.
A mathematician by training with a current focus on quantifying risk and uncertainty using causal, probabilistic models that combine data and knowledge (Bayesian networks).
He has published seven books and over 350 peer-reviewed articles. His work covers multiple application domains including health and law/forensics (he has been an expert witness in major criminal and civil cases).
Since 2020 Norman has been active in analysing data related to Covid risk.
Dr Geoff Pain
Geoff is a scientific consultant. In his undergraduate years, he studied Biochemistry, Chemistry, Physics, Pure and Applied Mathematics and Information Science.
After graduating and completing a PhD in Chemistry at Monash University he entered the traditional post-doctoral circuit, working at universities in Bristol, Cambridge and Adelaide, then returning to Monash.
He then was recruited by Telecom Australia (now Telstra) for a special project in Optoelectronic semiconductor crystal growth. At Telecom he completed a Graduate Diploma in Business Management majoring in Strategy and Innovation. This included qualification in the Law of Negligence.
Geoff took time off to run full-time as a candidate in the 1993 Federal election. He was then offered a fellowship at UWA to work on plasma deposition of materials in the Electronic Engineering Department.
After some private business ventures, NEC Japan invited him to the Microwave and Satellite Communications Systems division in Yokohama for a 3-year appointment in technical and change manager roles. Returning to Western Australia he ran a market research business which extended to investigation of Environmental Pollution and Toxicology projects for government and community groups. He worked in a private Genetics lab and "think-tank" on a wide range of projects.
He has returned to Victoria where he maintains a keen interest in politics. Geoff has published widely and was granted patents.
Dr Jeyanthi Kunadhasan
Dr Jeyanthi Kunadhasan was a Consultant anesthetist at a major regional Victorian public hospital and was in practice for more than 12 years.
She has a clinical interest in Patient Blood Management where she spearheaded many initiatives that sustainably brought down the unnecessary transfusion rates in major surgeries, leading to improved patient outcomes and lower cost to the health system.
Dr Wilson Sy
Dr Wilson Sy has held senior positions in academia, industry and government.
He is a quantitative and statistical analyst with several dozens of journal publications in physics, finance, economics, biology and medicine. He is highly experienced in data analysis in business and government.
He has held positions as Principal Researcher at the Australian Prudential Regulation Authority (“APRA”) and as senior adviser to the Australian Treasury for the Super System Review. Recently, he has published several journal articles on epidemiological data analysis of the COVID-19 pandemic.
Edward Dowd is currently a Founding Partner of Phinance Technologies, a global macro alternative investment firm.
He is also the author of the new book, "Cause Unknown: The Epidemic of Sudden Deaths in 2021 & 2022." (Release Date: Dec 13, 2022, Skyhorse Publishing).
Edward has worked on Wall Street most of his career, spanning both credit markets and equity markets. Some of the firms he worked for include HSBC, Donaldson Lufkin & Jenrette and Independence Investments.
Most notably, he worked at Blackrock as a portfolio manager where he managed a $14 billion Growth equity portfolio for ten years. After BlackRock, he founded OceanSquare Asset Management with two former BlackRock colleagues.
Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment for the study of cannabis-based therapeutics and blockchain technologies for tracking and verifying cannabis genetics.
Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and was Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next-generation sequencing and saw particular excitement and traction in human tumour sequencing.
Kevin initiated an R&D project to investigate chemFET semiconductor-based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature.
Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost a few years.
In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until it was acquired by Beckman Coulter. Kevin also managed the R&D for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters.
Tore A. Gulbrandsen
Tore is a Data Scientist with over 10 years of experience in process and product development and supervising statistical analyses for regulatory submission.
Having a passion for data and a slight suspicion of medical authorities based on personal experiences of failed treatment, he has followed key statistics with a critical eye from the start of the pandemic.
One of his specialties is recognizing anomalous data patterns, of which the last 3 years have seen in abundance, another is simulations and modelling.
Tore has been focusing on evaluating, modelling and predicting mortality statistics in the Nordics, but recently also in other countries.
Dr Astrid Lefringhausen
After finishing school, Astrid went on to study Biology and quickly focused on Molecular Biology and Immunology. In parallel working as a nurse in Radiology, teaching medicinal microbiology to nurse students at the German Red Cross and working in the Biotechnology research facility of Bayer.
Astrid gained a PhD in virology in 1996 and started the same year working for the Biotech industry, first in sales, and later as an export manager and technical trainer. From 1999 to 2006 Astrid worked internationally across Asia, Eastern Europe, Africa and South America as a staff and customer trainer in Molecular Biology, installing and training in the use of cell sorting equipment, and assisting in stem cell treatments in pediatric departments across the world.
Astrid moved to Australia in 2006, and since 2015 working in the diagnostics industry with Pathologies and Universities across Australia and New Zealand in the areas of Cell Chemistry, Immunohaematology, Immunology and Molecular Biology.
Dr Phillip Altman
Dr Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration in gaining new drug approvals.
He established Australia’s first contract research organisations (CROs), where he served as a Senior Industry Consultant for more than half of the pharmaceutical companies present in Australia. His career has seen him involved in more than one hundred clinical trials (Phase I through IV). He has been personally responsible for the market approval of numerous new drugs since joining the pharmaceutical industry in 1974.
A graduate of Sydney University with an Honours degree in Pharmacy, Master of Science and Doctor of Philosophy degrees (focusing on drug development, pharmacology and pharmaceutical chemistry), he co-founded and is a Life Member of the largest professional body of pharmaceutical industry scientists involved in clinical research and regulatory affairs.
More recently Dr. Altman has provided expert reports in relation to both the Australian and NZ Judicial Review and High Court cases in relation to the Covid vaccines.
Dr Aseem Malhotra
Dr Aseem Malhotra is an NHS-trained Consultant Cardiologist and an internationally renowned expert in the prevention, diagnosis and management of heart disease. He is an honorary council member of the Metabolic Psychiatry Clinic at Stanford University School of Medicine California. He is a founding member of Action on Sugar and was the lead campaigner highlighting the harm caused by excess sugar consumption in the United Kingdom, particularly its role in type 2 diabetes and obesity.
In 2015 he helped co-ordinate the Choosing Wisely campaign by the Academy of Medical Royal Colleges as lead author in a BMJ paper to highlight the risks of overuse of medical treatments. In the same year, he became the youngest member to be appointed to the board of trustees of the UK health think tank, The King's Fund which advises the government on health policy. Aseem is a frequent expert commentator in print and broadcast media and he has written scores of articles for a number of publications including the BMJ, British Journal of Sports Medicine, BMJ Open Heart, JAMA Internal Medicine, Prescriber, The Pharmaceutical Journal, European Scientist, The Guardian and Observer, BBC online, Huffington Post, The Daily Mirror, Daily Mail, The Daily Telegraph and the Washington Post. He is an international guest editor of the Journal of Evidence-based Healthcare.
Aseem has appeared in the Health Service Journal’s list of top 50 BME pioneers and has won a number of awards for his work to raise awareness of diet-related illness both in the UK and internationally. He is a pioneer of the lifestyle medicine movement in the UK and has had feature articles written about him in the New York Times, The Guardian, The Telegraph, The i, and Healthcare Leader. In 2018 he was ranked by software company Onalytica as the number 1 doctor in the world influencing obesity thinking.
In 2016 he was named in the Sunday Times Debrett's list as one of the most influential people in science and medicine in the UK a list that included Professor Stephen Hawking. His total Altmetric score (measure of impact and reach) of his medical journal publications since 2013 is over 10,000 making it one of the highest in the World for a clinical doctor during this period. His first book co-authored with Donal O' Neill, The Pioppi Diet, has become an international best seller. His second book, the 21-day immunity plan is a Sunday Times bestseller. During the first year of the Covid pandemic he was asked by the Secretary of State for Health, Matt Hancock to advise on the link between COVID and obesity and how best to reduce the population's risk of infection. His recently published third book A Statin Free Life is already a best seller.
Award-winning American Science Journalist Gary Taubes describes Aseem as someone who has “probably done more in the UK to inject sanity into nutrition science and the pharmaceutical industry debate than any human being alive”
Sir Richard Thompson, Past President of the Royal College of Physicians and former personal physician to Her Majesty The Queen said “Dr Aseem Malhotra is changing the face of medicine and his revolutionary book the Pioppi Diet should be read by everyone”
The Mayor of Manchester Andy Burnham said “ He’s really making people think differently about what they eat and how they live their life. Through his work he’s going to change many thousands of lives, millions of lives for the better”
Dr Jessica Rose
Jessica Rose is a Canadian researcher with a Bachelor Degree in Applied Mathematics and a Master's degree in Immunology from Memorial University of Newfoundland.
She also holds a PhD in Computational Biology from Bar Ilan University and 2 Post Doctoral degrees in Molecular Biology from the Hebrew University of Jerusalem, and in Biochemistry from the Technion Institute of Technology.
Her more recent research efforts are aimed at descriptive analyses of the Vaccine Adverse Event Reporting System (VAERS) data in efforts to make this data accessible to the public.
Dr Andrew Madry
Andrew Madry has a degree in Physics, a BSc (Hons) and a PhD from the University of Sydney. His PhD work was in acoustics and signal processing.
His early career was in the defence industry developing and testing sonar systems for the Royal Australian Navy. This involved designing and testing transducers and developing signal detection algorithms.
He had a second career in medical devices, initially leading a team at a major Sydney hospital developing technology for treating abnormal heart rhythms. That work in cardiology led to a career-long interest in understanding abnormal electrical signals in the heart and in particular developing algorithms for understanding the mechanisms of atrial fibrillation.
He has been a technical consultant since 2001 through his company Madry Technologies Pty Ltd. In consultancy, he has provided services to many companies including medical device companies Cochlear and Resmed, as well as defence and industrial companies. Andrew developed a software product, called Cardiac Electrophysiology Analysis System (CEPAS), that is used by researchers in the field of cardiac electrophysiology, in the USA, Japan and Australia.
In the last 5 years, Andrew has had a focus on the field of Data Science. Has been engaged in specific data projects implementing analytical techniques to resolve problems in a variety of domains. Part of Andrew’s work in Data Science has been providing customised training, based on years of experience in industry. Andrew is currently on the executive of the systems engineering society.
Clare is a medical journalist and science writer with over a decade experience of writing for doctors and the general public.
After two years of studying Medicine, Clare completed a Chemistry degree, followed by a Masters in Operational Research. She then worked for 8 years in industry in the UK as a statistician.
Clare turned to science writing and medical journalism in 2011. She has written for the ABC, New Scientist, the Springer Nature publishing group, Medical Observer, Australian Doctor and Spectator Australia.
Since December 2021, Clare has run projects on www.ClarityonHealth.org to examine the response to COVID-19 in Australia. Projects include the ‘The Australian Survey of Reasons for
COVID-19 Vaccination’ and the Mandate Update project, which tracks which employers are (and are not) mandating COVID-19 injections.
Working with Monica Smit, Reignite Democracy Australia, and a team of international volunteers on www.excessdeathstats.com, Clare’s current focus is to bring the phenomenon
of worldwide excess deaths to the attention of ordinary people and their elected representatives.
Dr Joseph Fraiman
Dr. Joseph Fraiman is an Emergency Medicine physician currently working in New Orleans, Louisiana, and the surrounding rural region.
Dr. Fraiman served as the medical manager of Louisiana’s Urban Search and Rescue Disaster Task Force 1. As an independent clinical scientist, he researches harm-benefit analysis of clinical interventions.
His publications regarding the COVID-19 mRNA vaccines include a re-analysis of serious harm from the original clinical trials, and on the FDA's safety surveillance system.
Dr Monique O'Connor
Dr O’Connor is a Consultant Psychiatrist and Australian expert in grief. She has had broad experience in clinical psychiatry, with special interest in Psychiatry of Old Age and Palliative
Care. She was the Director of Advanced Training in Psychiatry of Old Age in WA for five years.
Dr O'Connor developed an interest in grief following bereavement, a neglected subject in both medical training and service delivery. She undertook specialist training at the Center for Prolonged Grief, Columbia University under Dr Kathy Shear. In 2017 she established a private practice specialising in grief and providing Prolonged Grief Disorder Therapy.
Dr O’Connor shares her expertise through teaching, supervision and academic publication. She is a passionate advocate of grief education promotion in health sciences. Her ambition is to improve the management of high-risk bereavements, with the aim of reducing the burden of chronic mental illness and suicide risk associated with prolonged grief.
Dr O’Connor graduated in medicine from Kings College, University of London and trained in psychiatry in Western Australia.